A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of darbepoetin alfa beyond 16 weeks of
treatment in subjects with anemia of cancer who are not receiving chemotherapy.